Progyny Q4 EPS Jumps 25.5% to $0.48, Revenue Reaches $318.4M
Progyny reported Q4 adjusted EPS of $0.48, a 25.5% surprise over the $0.38 estimate and up from $0.42 year-ago, marking its fourth consecutive earnings beat. Revenue rose 6.8% year-over-year to $318.4 million, topping consensus by 4.8% despite a 16.9% YTD share decline.
1. Q4 Earnings and EPS Beat
Progyny reported adjusted EPS of $0.48 for Q4, surpassing the $0.38 consensus by 25.5% and improving from $0.42 a year earlier, marking its fourth straight quarter of earnings beats.
2. Revenue Growth Details
Revenue for the quarter reached $318.4 million, up 6.8% year-over-year from $298.4 million and topping estimates by 4.8%.
3. Share Performance and Outlook
Shares have declined 16.9% since the start of the year compared with a 1.5% gain for the S&P 500; analysts forecast Q1 EPS of $0.49 on $346.4 million in revenue and full-year EPS of $1.93 on $1.39 billion in revenue.